Incidence, clinical and laboratory features, and prognostic significance of immunophenotypic subgroups in acute lymphoblastic leukemia: the GEIL experience.
Garand
R
R
Laboratoire d'Hématologie du CHU, Nantes, France.
Béné
M C
MC
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015703:Antigens, CD / Q000032:analysis; D002648:Child; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007223:Infant; D007621:Karyotyping; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000401:mortality; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000235:genetics / Q000276:immunology* / Q000401:mortality; D011379:Prognosis; D015996:Survival Rate
D015703:Antigens, CD